User profiles for R. WALTER

Roland B. Walter

- Verified email at fredhutch.org - Cited by 16954

Robert Walter

- Verified email at lsuhs.edu - Cited by 2744

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

…, A Venditti, P Vyas, BL Wood, RB Walter… - Blood, The Journal …, 2018 - ashpublications.org
Measurable residual disease (MRD; previously termed minimal residual disease) is an
independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) that is …

The directed synthesis of biaryl compounds: modern concepts and strategies

…, R Walter, R Weirich - … International Edition in …, 1990 - Wiley Online Library
The preparation and utilization of specific biaryl systems, particularly those which suffer
hindered rotation, is a demanding goal not only in the synthesis of natural products and …

Association of measurable residual disease with survival outcomes in patients with acute myeloid leukemia: a systematic review and meta-analysis

NJ Short, S Zhou, C Fu, DA Berry, RB Walter… - JAMA …, 2020 - jamanetwork.com
Importance Measurable residual disease (MRD) refers to neoplastic cells that cannot be
detected by standard cytomorphologic analysis. In patients with acute myeloid leukemia (AML), …

In-datacenter performance analysis of a tensor processing unit

…, H Toma, E Tuttle, V Vasudevan, R Walter… - Proceedings of the 44th …, 2017 - dl.acm.org
Many architects believe that major improvements in cost-energy-performance must now
come from domain-specific hardware. This paper evaluates a custom ASIC---called a Tensor …

The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore–microtubule attachment and in maintaining the spindle assembly checkpoint

…, S LaTerra, C Zimmer, G Schnapp, R Walter… - The Journal of cell …, 2003 - rupress.org
The proper segregation of sister chromatids in mitosis depends on bipolar attachment of all
chromosomes to the mitotic spindle. We have identified the small molecule Hesperadin as an …

Structure–property relationships of irradiation grafted nano-inorganic particle filled polypropylene composites

MZ Rong, MQ Zhang, YX Zheng, HM Zeng, R Walter… - Polymer, 2001 - Elsevier
An irradiation grafting method was applied for the modification of nanoparticles so that the
latter can be added to polymeric materials for improving their mechanical performance, using …

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

…, PJM Valk, BL Wood, RB Walter… - Blood, The Journal …, 2021 - ashpublications.org
Measurable residual disease (MRD) is an important biomarker in acute myeloid leukemia (AML)
that is used for prognostic, predictive, monitoring, and efficacy-response assessments. …

Natural streams and the legacy of water-powered mills

RC Walter, DJ Merritts - Science, 2008 - science.org
… Taking beavers into account may not change Walter and Merritts' conclusions about the
natural form of streams, but their impacts need to be factored into the equation. …

A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia

…, HP Erba, PJ Stiff, RK Stuart, RB Walter… - Blood, The Journal …, 2013 - ashpublications.org
This randomized phase 3 clinical trial evaluated the potential benefit of the addition of
gemtuzumab ozogamicin (GO) to standard induction and postconsolidation therapy in patients …

[HTML][HTML] Venetoclax combined with low-dose cytarabine for previously untreated patients with acute myeloid leukemia: results from a phase Ib/II study

…, JZ Hou, W Fiedler, TL Lin, RB Walter… - Journal of Clinical …, 2019 - ncbi.nlm.nih.gov
… Patents, Royalties, Other Intellectual Property: AHW is a former employee of the Walter and
Eliza … AHW receives payments from the Walter and Eliza Hall Institute related to venetoclax. …